Login OPEN ICICI 3-in-1 Account

VIMTA LABS SHARE PRICE

Sector Healthcare
BSE 524394
NSE VIMTALABS
461.65
-15.90 (-3.33 %)
Buy
B
Sell
S
NSE BSE

Overview

1D 1W 1M 3M 6M 1Yr 3Yr 5Yr 10Yr Max
Price PE Ratio
 

We appreciate your patience. Your content is on the way.

Day Low

460.00

Day High

477.00

52 Week Low

236.03

52 Week High

589.00

All Time Low

6.28

All Time High

589.00

Open

477.00

Close

477.55

Volume

121,783

Mkt cap (Cr)

2,055.04

P/E ratio

30.53

P/B ratio

0.18%

Div yield

0.22%

6M return

-4.01%

1Y return

85.14%

SWOT Analysis

  • S
  • W
  • O
  • T

Technical Analysis

Moving Averages

EMA SMA
 

We appreciate your patience. Your content is on the way.

461.65 -3.33%

Current Price

  • Bullish Moving Averages
  • Bearish Moving Averages

Resistance and support

 

We appreciate your patience. Your content is on the way.

Company Financials

  • Profit and loss statement
  • Balance sheet
  • Quarterly Result
  • Ratio
 

We appreciate your patience. Your content is on the way.

Quick Results Snapshot

 

We appreciate your patience. Your content is on the way.

Shareholding Pattern

Summary

 

We appreciate your patience. Your content is on the way.

 

We appreciate your patience. Your content is on the way.

Historical Promoter Summary

 

We appreciate your patience. Your content is on the way.

Promoter Holding(%)

Historical FII Holdings

 

We appreciate your patience. Your content is on the way.

FII Holding(%)

Historical MF Holdings

 

We appreciate your patience. Your content is on the way.

MF Holding(%)

Stocks Comparison
Table Chart

 

We appreciate your patience. Your content is on the way.

Corporate Action

  • Announcement
  • Board Meeting
  • Dividend
  • Split
  • Rights
  • Events

Insider & Institutional Activity

  • Bulk Block Deals
  • Insider Trading & SAST
 

We appreciate your patience. Your content is on the way.

About Vimta Labs Ltd

Stock PE (TTM)

30.53

Promoter Holding

36.67%

Book Value

85.1245

ROCE

24.14%

ROE

19.44%

Vimta Labs Limited., established in 1984, is India`s most comprehensive contract research and testing organization, providing wide range of services to pharmaceutical, biopharmaceutical, food, consumer goods, electronic, electrical, agrochemical, healthcare, medical device and many other industries. Broadly, these services include: Drug discovery, development and drug life cycle management support services in the areas like preclinical research (GLP and non-GLP), clinical research, central lab, and cGMP as well as non-GMP analytical services for pharmaceutical and biopharmaceutical companies; Preclinical research and testing services for medical device companies; Contract research and testing for Agro-science companies; Food testing and analytical development services to support manufacturers, processors, farmers, retailers, traders, exporters, regulators; Clinical diagnostics services to patients, clinicians, hospitals and Environmental regulatory services such as impact assessments and post project monitoring, to industries such as infrastructure, power, cement, oil & gas, mining etc; EMI/EMC testing for electronic and electrical products. In 1997, the Company entered into a Joint Venture with Russian Centre for Testing and Certification, ROSTEST Moscow with an investment of 24% of the total Paidup Captial. The main essence of this Joint Venture was to diversify the activities in to preshipment inspection services for all Indian exports to Russia. During 2002, the company began to offer Clinical Diagnostics Services. Clinical Specialty Diagnostics has been an internal requirement to screen the clinical trial subjects. Facilities were created in the year 2000 to speed up the clinical trials. During the year 2006-07, the Analytical and Clinical Reference Lab facilities was shifted from the existing Cherlapally Facility to the newly established Life Sciences Facility in S.P.Biotech Park, Genome Valley, Hyderabad which started commercial operations from September, 2006. During the year 2020 Company acquired 100% Equity Shares of Emtac Laboratories Private Limited, on 04th March 2020, making Emtac a wholly owned subsidiary of the Company. In 2024-25, Emtac Laboratories Pvt. Ltd., the 100% owned subsidiary got merged with the Company effective from 01 April, 2024, thereby consolidating its presence in the Electronics and Electrical testing.

Vimta Labs share price as on 24 Jun 2025 is Rs. 461.65. Over the past 6 months, the Vimta Labs share price has decreased by 4.01% and in the last one year, it has increased by 85.14%. The 52-week low for Vimta Labs share price was Rs. 236.03 and 52-week high was Rs. 589.

Read More
Registered Office  
Registrars  
Management  
Listing Info  

524394

VIMTALABS

INE579C01029

Jul

Vimta Labs Ltd FAQs

You can buy Vimta Labs Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Vimta Labs Ltd Share.

Company share prices and volatile and keep changing according to the market conditions. As of Jun 23, 2025 03:59 PM the closing price of Vimta Labs Ltd was Rs.461.65.

The latest PE ratio of Vimta Labs Ltd as of Jun 23, 2025 03:59 PM is 30.53

The latest PB ratio of Vimta Labs Ltd as of Jun 23, 2025 03:59 PM is 0.18

The 52-week high of Vimta Labs Ltd share price is Rs. 589.00 while the 52-week low is Rs. 236.03

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of Jun 23, 2025 03:59 PM, the market cap of Vimta Labs Ltd stood at Rs. 2,055.04 Cr.

Market Outlook

View all
 

We appreciate your patience. Your content is on the way.